Literature DB >> 15527964

Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3.

Maki Daniels1, Vishal Dhokia, Laurent Richard-Parpaillon, Shin-Ichi Ohnuma.   

Abstract

The Cip/Kip family of mammalian cyclin-dependent kinase (cdk) inhibitors plays important roles in development, particularly in cell fate determination and differentiation, in addition to their function of blocking cell cycle progression. We have identified two novel members of the Kip/Cip cdk inhibitor family, p16Xic2 and p17Xic3, from Xenopus laevis. Sequence analysis revealed that p16Xic2 and p17Xic3 are orthologues of mammalian p21Cip1 and p27Kip1, respectively. Overexpression of these inhibitors results in cell cycle arrest by inhibition of cdk2 activity. Interestingly, the expression of these inhibitors is highly developmentally regulated. p16Xic2 is highly expressed in differentiating somite, tail bud, lens, and cement gland, while p17Xic3 is expressed in the central nervous system. In a retinal cell fate determination assay, both p16Xic2 and p17Xic3 have an activity that influences cell fate determination. These observations suggest that p16Xic2 and p17Xic3 might be involved in cell fate determination in a tissue-specific manner by coordinating proliferation and differentiation as observed with p27Xic1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527964     DOI: 10.1016/j.gene.2004.07.038

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

Review 1.  Nucleoside diphosphate kinases (NDPKs) in animal development.

Authors:  Krisztina Takács-Vellai; Tibor Vellai; Zsolt Farkas; Anil Mehta
Journal:  Cell Mol Life Sci       Date:  2014-12-24       Impact factor: 9.261

Review 2.  Cell cycle control in the early embryonic development of aquatic animal species.

Authors:  Joseph C Siefert; Emily A Clowdus; Christopher L Sansam
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-10-17       Impact factor: 3.228

3.  The CRL4Cdt2 ubiquitin ligase mediates the proteolysis of cyclin-dependent kinase inhibitor Xic1 through a direct association with PCNA.

Authors:  Dong Hyun Kim; Varija N Budhavarapu; Carlos R Herrera; Hyung Wook Nam; Yu Sam Kim; P Renee Yew
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

4.  Polycomb repressive complex PRC2 regulates Xenopus retina development downstream of Wnt/β-catenin signaling.

Authors:  Issam Aldiri; Kathryn B Moore; David A Hutcheson; Jianmin Zhang; Monica L Vetter
Journal:  Development       Date:  2013-06-05       Impact factor: 6.868

Review 5.  The Xenopus cell cycle: an overview.

Authors:  Anna Philpott; P Renee Yew
Journal:  Mol Biotechnol       Date:  2008-02-12       Impact factor: 2.695

6.  Normal levels of p27 are necessary for somite segmentation and determining pronephric organ size.

Authors:  Richard W Naylor; Robert J Collins; Anna Philpott; Elizabeth A Jones
Journal:  Organogenesis       Date:  2009-10       Impact factor: 2.500

7.  YAP controls retinal stem cell DNA replication timing and genomic stability.

Authors:  Pauline Cabochette; Guillermo Vega-Lopez; Juliette Bitard; Karine Parain; Romain Chemouny; Christel Masson; Caroline Borday; Marie Hedderich; Kristine A Henningfeld; Morgane Locker; Odile Bronchain; Muriel Perron
Journal:  Elife       Date:  2015-09-22       Impact factor: 8.140

8.  Proteolysis of Xenopus Cip-type CDK inhibitor, p16Xic2, is regulated by PCNA binding and CDK2 phosphorylation.

Authors:  Xi-Ning Zhu; Dong Hyun Kim; Horng-Ru Lin; Varija N Budhavarapu; Herbert B Rosenbaum; Paul R Mueller; P Renee Yew
Journal:  Cell Div       Date:  2013-04-22       Impact factor: 5.130

9.  Xenopus NM23-X4 regulates retinal gliogenesis through interaction with p27Xic1.

Authors:  Toshiaki Mochizuki; Aikaterini Bilitou; Caroline T Waters; Kamran Hussain; Massimo Zollo; Shin-ichi Ohnuma
Journal:  Neural Dev       Date:  2009-01-05       Impact factor: 3.842

10.  Cardiac differentiation in Xenopus requires the cyclin-dependent kinase inhibitor, p27Xic1.

Authors:  Mehregan Movassagh; Anna Philpott
Journal:  Cardiovasc Res       Date:  2008-04-27       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.